Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations

Figure 1

Distribution of histidine-rich glycoprotein (HRG) serum levels in controls and lung cancer patients with stage IV/extensive disease and locally advanced inoperative stage IIIAB/limited disease. Data are presented as median, interquartile range, and maximum and minimum values. Numbers on the graph represent values in comparison to control and between lung cancer patient groups. LD: limited disease; ED: extensive disease.